EPIDEMIOLOGY OF CUTANEOUS CANCERS--A MODEL FOR HUMAN CARCINOGENESIS
皮肤癌的流行病学--人类致癌的模型
基本信息
- 批准号:3820312
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:adipose tissue basal cell carcinoma cancer prevention cancer registry /resource cancer risk carcinogenesis carotene clinical chemistry enzyme induction /repression human subject interview lifestyle light adverse effect longitudinal human study melanoma neoplasm /cancer diagnosis nutrient intake activity nutrition related neoplasm /cancer nutrition related tag ornithine decarboxylase pigmentation questionnaires radiation carcinogen reflection spectrometry skin skin neoplasms squamous cell carcinoma ultraviolet radiation vitamin D vitamin metabolism
项目摘要
Three collaborative population based studies of skin cancer are
proposed which will focus upon ultraviolet light, dietary factors,
biochemical markers and other known or suspected epidemiologic
risk factors and their interrelationship. Cases and controls will
be obtained from the 6 counties of Southeastern Arizona. Two
of the proposed studies will use a case-control design, with cases
defined by a pathologically confirmed diagnosis of cutaneous
basal or squamous cell carcinoma for one study and cases defined
by a pathologically confirmed diagnosis of melanoma for the
second study. For each case, 2 persons from the population of
these counties, frequency matched by age, sex, ethnic origin, and
geographic region, will be selected as controls using random digit
dialing. Due to the similar age and sex distribution for
melanoma and nonmelanoma (i.e. basal and squamous cell
carcinoma) cases, a large proportion of persons selected as
controls for one study are anticipated to be matched and used as
controls for the second case-control study.
The third proposed study will use a prospective cohort design and
include all cases of nonmelanoma included in the first case-
control study described above plus added subjects with 1 or more
prior nonmelanoma skin cancers. Cohort subjects will have had
their nonmelanoma skin cancer pathologically confirmed
completely removed and will be followed for the diagnosis of
subsequent skin cancers.
All subjects will be interviewed at the time on study.
Nonmelanoma subjects will also be interviewed at 12 month
intervals. Blood and tissue specimens will be collected,
processed and stored for all study subjects at the time on study.
These specimens will be kept in storage for analysis during 1989-
90 (year 4 of this project) and after the interview, data has been
analyzed. Analyses of specimens will include retinyl palmitate,
beta-carotene and other micronutrients identified from analysis
of dietary intake data obtained during interview. A four year
total duration for all studies is planned and includes analysis and
preparation of manuscripts.
三项基于人群的皮肤癌合作研究是
建议将重点放在紫外线,饮食因素,
生化标志物和其他已知或疑似流行病学
风险因素及其相互关系。 病例和对照组将
从亚利桑那州东南部的6个县获得。 两
的拟议研究将使用病例对照设计,
定义为经病理证实的皮肤病诊断
1项研究中的基底细胞癌或鳞状细胞癌和定义的病例
通过病理学确诊的黑色素瘤,
第二项研究。 每起案件中,
这些县,按年龄、性别、民族血统和
地理区域,将使用随机数字选择作为对照
正在拨号 由于年龄和性别分布相似,
黑色素瘤和非黑色素瘤(即基底细胞和鳞状细胞
癌症)病例中,很大一部分人被选为
一项研究的对照预期匹配并用作
第二次病例对照研究的对照。
第三项拟议研究将采用前瞻性队列设计,
包括第一个病例中包括的所有非黑色素瘤病例-
上述对照研究加上增加的受试者有1个或多个
有过非黑色素瘤皮肤癌病史 队列受试者将接受
他们的非黑色素瘤皮肤癌经病理证实
完全切除,并将随访诊断为
随后的皮肤癌。
所有受试者将在研究期间接受访谈。
非黑色素瘤受试者也将在12个月时接受访谈
的间隔 将采集血液和组织标本,
在研究时为所有研究受试者处理和储存。
这些样本将储存起来,以便在一九八九年进行分析。
90(该项目的第4年),访谈后,数据已
分析了 样本分析将包括棕榈酸视黄酯,
β-胡萝卜素和其他微量营养素
在访谈中获得的饮食摄入量数据。 四年
计划所有研究的总持续时间,包括分析和
准备手稿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS E MOON其他文献
THOMAS E MOON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS E MOON', 18)}}的其他基金
CORE--CLINICAL DATA MANAGEMENT AND BIOSTATISTICS LABORATORY
核心——临床数据管理和生物统计实验室
- 批准号:
6110387 - 财政年份:1999
- 资助金额:
-- - 项目类别:
CORE--CLINICAL DATA MANAGEMENT AND BIOSTATISTICS LABORATORY
核心——临床数据管理和生物统计实验室
- 批准号:
6273003 - 财政年份:1998
- 资助金额:
-- - 项目类别:
相似海外基金
Precision oncology to define basal cell carcinoma (BCC) with high-risk histopathological subtypes
精准肿瘤学定义具有高风险组织病理学亚型的基底细胞癌 (BCC)
- 批准号:
485125 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Analysis of intraoperative videos from basal cell carcinoma removal surgery
基底细胞癌切除手术术中视频分析
- 批准号:
574060-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Developing Improved Models of Basal Cell Carcinoma to Evaluate Tumor-Drug Response
开发改进的基底细胞癌模型以评估肿瘤药物反应
- 批准号:
10518702 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Applied Research and Development Grants - Level 3
Predicting drug response for basal cell carcinoma by comprehensive genomic analysis.
通过综合基因组分析预测基底细胞癌的药物反应。
- 批准号:
21K16898 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10066547 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10212968 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10430040 - 财政年份:2020
- 资助金额:
-- - 项目类别: